Newsroom

Meet Proteona at the CAR-TCR Summit Asia in Shanghai

Meet the Proteona team at the CAR-TCR Sumit Asia in Shanghai, China

Innovative combined genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications

SINGAPORE, 1 June 2019 - The Proteona team will attend the CAR-TCR Summit Asia from the 19th to the 20th June 2019, taking place in Shanghai, China. The CAR-TCR Summit Asia focusses on clinical application of cell immunotherapies, especially CAR T and TCR therapies. It covers important topics such as new technologies to improve CAR T manufacturing process.

The team will be available during the conference to share about the new ESCAPETM CAR T platform. This new product will be available for comprehensive characterization of CAR T immunotherapeutics, and can be integrated into all stages of CAR T therapy from quality control to analysing patient follow-up samples.

Conference details

Schedule a meeting


For media queries, please contact:

Dr Andreas Schmidt
Proteona
Email: info@proteona.com

About Proteona

Proteona Pte. Ltd. is a new biomedical company based in Singapore and San Diego that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.

www.proteona.com